Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Motor Units00:46

Motor Units

A motor unit consists of two main components: a single efferent motor neuron (i.e., a neuron that carries impulses away from the central nervous system) and all of the muscle fibers it innervates. The motor neuron may innervate multiple muscle fibers, which are single cells, but only one motor neuron innervates a single muscle fiber.
Motor Units01:13

Motor Units

The motor unit is a fundamental component of the neuromuscular system and plays a crucial role in coordinating muscle contractions. It consists of a somatic motor neuron, which connects and controls multiple skeletal muscle fibers, forming a single functional segment. The axon of the motor neuron branches out and establishes synaptic connections known as neuromuscular junctions with individual muscle fibers within the motor unit.
Motor units come in different sizes, with smaller units...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement science as the engine for the next generation of learning health networks.

Frontiers in health services·2026
Same author

Identifying emergency department patients at high risk for opioid overdose using natural language processing and machine learning.

Journal of substance use and addiction treatment·2025
Same author

Comparisons of mental health treatment frequency and risk of suicidal thoughts and behaviors among youth.

Psychiatry research·2024
Same author

A personalised activity programme helps reduce fatigue in people after Guillain-Barré Syndrome in a replicated single system design.

Disability and rehabilitation·2024
Same author

Authors' response.

American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics·2023
Same author

Analgesia following controlled Urtica ferox extract exposure.

Internal medicine journal·2023
Same journal

A multimodal deepsurv approach: integrating radiomics and clinical factors for brain metastasis survival prediction.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same journal

CSF-venous fistula with subdural hematoma in the setting of chronic anticoagulation.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same journal

Tumor control and cranial nerve outcomes after Gamma Knife radiosurgery for Glomus jugulare tumors: a systematic review, meta-analysis, and institutional failure pattern analysis.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same journal

Clinical utility of maximal and minimal intensity projections in T2-weighted MRI for neurosurgical planning.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same journal

Clinical and CT perfusion outcomes after direct STA-MCA bypass in moyamoya and non-moyamoya steno-occlusive disease: an Indonesian single-center cohort.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same journal

Effect of non-consecutive treatment during hypofractionated stereotactic radiosurgery (HF-SRS) for brain metastases.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

Multifocal motor neuropathy.

Suraj Ashok Muley1, Gareth J Parry

  • 1Barrow Neurological Institute, Department of Neurology, Phoenix, AZ 85013, USA. Suraj.Muley@thebni.org

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|June 30, 2012
PubMed
Summary
This summary is machine-generated.

Multifocal motor neuropathy (MMN) is an inflammatory nerve disorder attacking motor nerves. Diagnosis traditionally requires conduction block (CB) evidence, though MMN without CB is debated.

More Related Videos

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method
08:25

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method

Published on: June 7, 2018

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Related Experiment Videos

Last Updated: May 21, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method
08:25

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method

Published on: June 7, 2018

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Area of Science:

  • Neurology
  • Immunology
  • Neurophysiology

Background:

  • Multifocal motor neuropathy (MMN) is a rare disorder affecting multiple motor nerves.
  • Historically, diagnosis relied on electrophysiological evidence of conduction block (CB) in motor axons.
  • The relationship between MMN with and without demonstrable CB remains a subject of debate.

Purpose of the Study:

  • To review the current understanding of multifocal motor neuropathy.
  • To discuss the diagnostic criteria and potential underlying pathologies.
  • To outline current and emerging treatment strategies for MMN.

Main Methods:

  • Review of existing literature on MMN.
  • Analysis of electrophysiological findings in MMN patients.
  • Discussion of immunological markers and pathological mechanisms.

Main Results:

  • MMN is characterized by selective motor nerve involvement, with or without CB.
  • The underlying pathology may involve segmental demyelination or primary axonopathy.
  • Anti-GM1 antibodies are present in some patients, but their pathogenicity is uncertain.

Conclusions:

  • MMN is an immune-mediated neuropathy targeting motor nerves.
  • Diagnostic criteria are evolving to include cases without clear CB.
  • Intravenous immunoglobulin is a primary treatment, with other immunosuppressants also showing efficacy.